Status:
COMPLETED
A Retrospective Analysis: the Influence of Caltrate Supplement on the Effect of Mesalazine in Ulcerative Colitis
Lead Sponsor:
Second Affiliated Hospital of Wenzhou Medical University
Conditions:
Ulcerative Colitis
Vitamin D Deficiency
Eligibility:
All Genders
18+ years
Brief Summary
Aims:Retrospectively observe the effects of Caltrate supplementation on the clinical effect of mesalazine in patients with ulcerative colitis. Design: From January 2015 to December 2020, through retr...
Detailed Description
1. The research has been approved by the Medical Ethics Committee of the Second Affiliated Hospital of Wenzhou Medical University. 2. According to the "Consensus on Diagnosis and Treatment of Inflamma...
Eligibility Criteria
Inclusion
- Clearly diagnosed patients with UC
- Took mesalazine for at least 12 months
Exclusion
- had recent supplementation of vitD3
- had prior or concomitant use of other biologic agent, glucocorticoid and/or immunomodulators at the time of enrollment or follow up
- Co-morbid with other autoimmune diseases
- Severe liver and kidney dysfunction
Key Trial Info
Start Date :
January 1 2015
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 31 2021
Estimated Enrollment :
74 Patients enrolled
Trial Details
Trial ID
NCT04276649
Start Date
January 1 2015
End Date
March 31 2021
Last Update
September 14 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
SAHWenzhouMU
Wenzhou, Zhejiang, China, 325000